Showing results (301-310 of 725) with videos related to
Sort By:
Pageof 73
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1988
Effects of a nonpressor dose of neuropeptide Y on cardiac output, regional blood flow distribution and plasma renin, vasopressin and catecholamine levelsJ F Aubert, M Burnier, B Waeber, et al.Journal of Cardiovascular Pharmacology|January 1, 1987
Pharmacokinetics of the converting enzyme inhibitor cilazapril in normal volunteers and the relationship to enzyme inhibition: development of a mathematical modelR J Francis, A N Brown, L Kler, et al.British Journal of Clinical Pharmacology|May 1, 1981
Effect of a new angiotensin converting enzyme inhibitor MK 421 and its lysine analogue on the components of the renin system in healthy subjectsD B Brunner, G Desponds, J Biollaz, et al.Clinical Pharmacology and Therapeutics|June 1, 1987
Pharmacokinetics of synthetic atrial natriuretic peptides in normal menJ Biollaz, L T Callahan, J Nussberger, et al.The Journal of Clinical Investigation|August 1, 1987
Protection by recombinant alpha 1-antitrypsin Ala357 Arg358 against arterial hypotension induced by factor XII fragmentM Schapira, M A Ramus, B Waeber, et al.Lancet (London, England)|September 26, 1987
Are some hypertensive patients overtreated? A prospective study of ambulatory blood pressure recordingB Waeber, U Scherrer, A Petrillo, et al.Archives Des Maladies Du Coeur Et Des Vaisseaux|June 1, 1988
[Arterial hypertension with hyperkalemia, tubular acidosis and normal renal function: Gordon syndrome and/or pseudohypoaldosteronism type II?]J L Ader, B Waeber, J M Suc, et al.European Journal of Clinical Pharmacology|January 1, 1985
Haemodynamic and pharmacological effects of the converting enzyme inhibitor CGS 14824A in normal volunteersM D Schaller, J Nussberger, B Waeber, et al.American Journal of Hypertension|March 11, 2000
Update on the clinical pharmacology of candesartan cilexetilH GavrasBlood Pressure. Supplement|January 1, 1997
Angiotensin II antagonism: a new avenue of hypertension managementH GavrasPageof 73